18 May 2009

ASCO 2009 - Progress in Oncology

Media Event

New clinical data on lead oncology compounds presented at ASCO 2009: Oncology experts about results of the LUX-Lung study programme in lung cancer.

20 April 2009

Educational seminar on stroke prevention in atrial fibrillation

Media Event

Leading medical experts and patients who are living with atrial fibrilation provide insight into the limitations of current anticoagulation therapy and the impact this has on patients, carers and doctors.

Cardiology23 - 26 October 2008

19th Great Wall International Congress of Cardiology

Media Event

The results and implications of the Landmark ONTARGET® Trial Programme with a specific focus on cardiovascular care in Asia-Pacific.

05 October 2008

UPLIFT® Breaking News

Media Event

The results of the landmark trial in chronic obstructive pulmonary disease (COPD), UPLIFT® will be announced during the European Respiratory Society conference.

30 August - 3 September 2008

European Society of Cardiology Congress 2008 (ESC)

Media Event

The landmark ONTARGET® Trial Programme continues to further cardiovascular care with the announcement of the TRANSCEND® Trial results exclusively at the ESC Congress 2008.

Restless Legs Syndrome26 August 2008

European Federation of Neurological Societies (EFNS)

Media Event

"The Reality of Restless Legs Syndrome"

A visit to a sleep laboratory followed by presentations from leading experts in the field of neurology and also insights on RLS diagnosis in the primary healthcare setting.

Parkinson's Disease25 August 2008

European Federation of Neurological Societies (EFNS)

Media Event

"Beyond Perception: The Seen and Unseen Expressions of Parkinson's Disease"

Internationally renowned experts present on the medical considerations involved with the current management of Parkinson's disease to achieve motor control and non-motor benefits.

18 - 21 May 2008

ONTARGET® results: a perspective on the Latin American region

Media Event

Exclusively for Latin American media, leading cardiologists present the ONTARGET® trial results and discuss the important implications for emerging economies around the globe and the implications for clinical practice in Latin America.

07 May 2008

The Science of Desire: Exploring the neurobiological connection

Media Event

Up to one in ten of the female population suffer from Hypoactive Sexual Desire Disorder. World-renowned sexual health experts will provide insight during this media event in New Orleans, USA.

29 March - 01 April 2008

Annual Scientific Sessions of the American College of Cardiology (ACC)

Media Event

The ONTARGET® trial results are presented during the Annual Scientific Sessions of the American Co12th EFNS in Madrid, Spain

05 March 2008

International Journalist Summit on Venous Thromboembolism

Media Event

University Hospital Mainz: "Introduction to knee replacement surgery"
Boehringer Ingelheim Corporate Headquarters: "Thromboembolic Disease: A Global Priority"

03-06 September 2007

12th World Conference on Lung Cancer

Media Event

"The second generation: revealing the next chapter in the evolution of lung cancer care"

Parkinson's Disease28 August 2007

European Federation of Neurological Societies (EFNS)

Media Event

"A Panoramic Picture of Parkinson's Disease"

Restless Legs Syndrome27 August 2007

European Federation of Neurological Societies (EFNS)

Media Event

"Dispelling the Mystery Behind Restless Legs Syndrome"

HIV/AIDS23 July 2007

4th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention

"Women Living Positive"

11 July 2007

XXIst Congress of the International Society on Thrombosis & Haemostasis (ISTH)

"Clot Prevention Following Orthopaedic Surgery - A New Beginning?"

21 April 2009

Boehringer Ingelheim Annual Press Conference 2009

Boehringer Ingelheim presents results of the business year 2008 and outlook 2009. Venue: Boehringer Ingelheim Headquarters Ingelheim, Germany

Research & Development17 October 2008

2nd International Boehringer Ingelheim Research & Development Press Conference

The latest on new generation compounds and new therapeutic approaches - an exclusive update on progress in the Boehringer Ingelheim pipeline.

08 November 2006

R & D Press Conference 2006

Tomorrow's Targeted Therapies - Boehringer Ingelheim's Research and Development Activities.